Generic Name and Formulations:
Dinoprostone 0.5mg/3g; endocervical gel.
Indications for PREPIDIL:
Ripening an unfavorable cervix in pregnant women at or near term.
See full labeling.
Where oxytocics or prolonged uterine contractions are inappropriate, including: history of cesarean section, major uterine surgery, presence of cephalopelvic disproportion, difficult labor, traumatic delivery, 6 or more previous term pregnancies, nonvertex presentation, hyperactive or hypertonic uterine patterns, fetal distress where delivery is not imminent. Ruptured membranes. Placenta previa or unexplained vaginal bleeding. When vaginal delivery is not indicated. Concomitant oxytocics.
For hospital use only when immediate intensive care and acute surgical facilities can be provided. Avoid contact with skin. Monitor uterine activity, fetal status, cervix. History of/or asthma. Glaucoma or increased intraocular pressure. If hypersensitivity reaction is suspected, remove Prepidil gel if possible. Renal or hepatic dysfunction. Pregnancy (Cat.C).
Potentiates oxytocics. Oxytocin: a dosing interval of 6–12hrs is needed, if used following Prepidil administration.
Maternal: Uterine rupture, uterine contraction abnormality, GI upset, back pain, warm feeling in vagina, fever, premature rupture of membranes. Fetal: Heart rate abnormality, fetal depression, fetal acidosis. Amnionitis and intrauterine fetal sepsis associated with extra-intrauterine administration.
Prefilled-syringe applicator (w. catheters)—5
Sign Up for Free e-newsletters
- Study Finds Association Between Folate Intake and Risk of Cutaneous Melanoma
- Qualitative Analysis of Myeloma Patients' Experience Following Hematopoietic Stem Cell Transplant
- Melanoma Outcomes Improved With Nivolumab Alone or Plus Ipilimumab
- Involved-Field Radiotherapy Plus Chemotherapy Prolonged PFS in Follicular Lymphoma
- Patient Fears of Placebo Use in Clinical Trials
- Implementing an Ambulatory Adherence Program May Improve Oral Anticancer Medications Compliance
- Exercise Habits Influence Mortality in Adult Survivors of Childhood Cancer
- Managing Dyspnea With Fentanyl in Patients With Cancer at End of Life
- CALM: A Depression Intervention for Cancer Patients at the End of Life
- High BMI Among Premenopausal Women May Improve Risk for Breast Cancer
- Genetic Link Between Depression and Breast Cancer Remains Unclear
- Bariatric Surgery Reduced Risk of Some Cancers in Obese Patients
- Bleeding Disorder Treatments: Hemophilia A
- Guideline Recommendations Offer No OS Benefit for Younger Patients With Rectal Cancer
- Bleeding Disorder Treatments: von Willebrand Disease
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|